Stock screener

GSK

Conviction 14HealthcareScan · Thu, Sep 24, 2026

GSK plc (GSK) closed at $49.64 (-0.14%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 46, RS Rating 69, -18.9% from its 52-week high, +0.0% year to date. Sector: Healthcare · Drug Manufacturers - General.

GSK$49.64-0.14%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 2.96M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
GSK plcDrug Manufacturers - Generalwww.gsk.com ↗
Price49.64
Change-0.14%
Gap-0.18%
Rel volume0.92×
Avg volume2.92M
Avg $ vol146.02M
SMA 2049.97
SMA 5050.94
SMA 20052.42
Price vs 50-2.56%
Price vs 200-5.31%
MA stackbearish
50/200 cross—
Supertrenddown · 51.33
RSI (14)46
MACD hist0.09
MACD crossbull · 6d
Stoch %K / %D52 / 60
ADX (14)9
+DI / −DI26 / 28
RSI divergence—
MACD divergence—
ATR %2.06%
ADR %1.51%
52w high61.18
52w low39.52
From 52w high-18.86%
Above 52w low+25.61%
New 52w highNo
SqueezeOff
Bollinger width7.25%
%B0.41
Donchian pos48.77%
Donchian high51.52
Donchian low47.85
AVWAP (52w high)53.14
vs AVWAP high-6.58%
AVWAP (52w low)51.00
vs AVWAP low-2.66%
OBV trendFlat
Chaikin MF (20)-0.09
Today vs 20d0.92×
Avg vol (14d)2.96M
Avg vol (20d)2.92M
Avg $ vol (20d)146.02M
Market cap99.5B
RS Rating69 / 99
RS 3m (vs SPY)-8.83%
RS 6m (vs SPY)-26.07%
RS line new highNo
Trend template3/8
Technical rank35.0
1 week-2.78%
1 month-4.67%
3 months-4.34%
6 months-9.25%
1 year+22.51%
YTD+0.02%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target65.00
Target upside30.94%
Analyst ratingHold
Institutional17.24%
Ent. value99.5B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out2.03B
Employees66.84K
ListedWed, Aug 18, 1976
Free float1.94B
Float %96.9%
Short interest13.55M
Days to cover4.8d
Short volume56.2%
Squeeze score36 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.36 vs $1.27
Last surprise+7.1% beat
Setup gradeD
Conviction14 / 100
Pattern quality—
Tech rank35.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance53.02
Support48.36
Days since event—
Candle confirm—

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jul 13
    1 scan
  2. Breaking out now
    Jul 28
    1 scan

Recent news

Congress activity

Disclosed STOCK Act trades in GSK · 10 recent

All disclosures →
MemberSideAmount
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-31
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-09-23
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-11-18
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-08-04
Buy$1K–$15K
Robert B. Aderholt
Robert B. Aderholt
house · R · AL · traded 2025-07-28
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-24
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Buy$1K–$15K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-04-21
Sell$1K–$15K
Bruce Westerman
Bruce Westerman
house · R · AR · traded 2025-03-03
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in GSK

No recent insider (Form 4) filings in GSK. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GSK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.